In vitro and in vivo inhibition of LPS-stimulated tumor necrosis factor-α secretion by the gallotannin β-D-pentagalloylglucose

被引:61
作者
Feldman, KS
Sahasrabudhe, K
Lawlor, MD
Wilson, SL
Lang, CH
Scheuchenzuber, WJ
机构
[1] Penn State Univ, Dept Chem, University Pk, PA 16802 USA
[2] Penn State Univ, Dept Life Sci Consortium, University Pk, PA 16802 USA
[3] Penn State Univ, Milton S Hershey Med Ctr, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA
关键词
D O I
10.1016/S0960-894X(01)00332-8
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The naturally occurring gallotannin beta -D-pentagalloylglucose (beta -PGG) decreases tumor necrosis factor-alpha (TNF-alpha) output from human peripheral blood mononucleocytes exposed to lipopolysaccharide (LPS) by as much as 90% (vs control) at similar to 5 muM concentration. A qualitatively similar but less pronounced effect (similar to 50% decrease) was observed in the serum of rats dosed with both LPS and beta -PGG. These results may have relevance to therapies that target disease states characterized by an overproduction of TNF-alpha. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1813 / 1815
页数:3
相关论文
共 18 条
  • [1] BEUTLER B, 1995, J INVEST MED, V43, P227
  • [2] Agents that block TNF-alpha synthesis or activity
    Black, RA
    Bird, TA
    Mohler, KM
    [J]. ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 32, 1997, 32 : 241 - 250
  • [3] E5531, A PURE ENDOTOXIN ANTAGONIST OF HIGH POTENCY
    CHRIST, WJ
    ASANO, O
    ROBIDOUX, ALC
    PEREZ, M
    WANG, YA
    DUBUC, GR
    GAVIN, WE
    HAWKINS, LD
    MCGUINNESS, PD
    MULLARKEY, MA
    LEWIS, MD
    KISHI, Y
    KAWATA, T
    BRISTOL, JR
    ROSE, JR
    ROSSIGNOL, DP
    KOBAYASHI, S
    HISHINUMA, L
    KIMURA, A
    ASAKAWA, N
    KATAYAMA, K
    YAMATSU, I
    [J]. SCIENCE, 1995, 268 (5207) : 80 - 83
  • [4] EDWARDS CK, 1994, XENOBIOTIC INDUCED I, P97
  • [5] Immunostimulation by plant polyphenols:: A relationship between tumor necrosis factor-α production and tannin structure
    Feldman, KS
    Sahasrabudhe, K
    Smith, RS
    Scheuchenzuber, WJ
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (07) : 985 - 990
  • [6] Feldman KS, 2000, BASIC LIFE SCI, V66, P101
  • [7] HASLAM E, 1998, PRACTICA POLYPHENOLI
  • [8] KANOF ME, 1991, CURRENT PROTOCOLS IM, V1
  • [9] Efficient total synthesis of the natural products 2,3,4,6-tetra-O-galloyl-d-glucopyranose, 1,2,3,4,6-penta-O-galloyl-beta-D-glucopyranose and the unnatural 1,2,3,4,6-penta-O-galloyl-alpha-D-glucopyranose
    Khanbabaee, K
    Lotzerich, K
    [J]. TETRAHEDRON, 1997, 53 (31) : 10725 - 10732
  • [10] LIPOPOLYSACCHARIDE ANTAGONISTS
    LYNN, WA
    GOLENBOCK, DT
    [J]. IMMUNOLOGY TODAY, 1992, 13 (07): : 271 - 276